# Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant

> **NCT01328132** · PHASE4 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 20 (estimated)

## Conditions studied

- Other Complications of Liver Transplant

## Interventions

- **DRUG:** Saline
- **DRUG:** 25% albumin

## Key facts

- **NCT ID:** NCT01328132
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328132, "Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01328132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*